Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2023 Mar 1:244:109769.
doi: 10.1016/j.drugalcdep.2023.109769. Epub 2023 Jan 14.

Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics

L M Ruglass  1 , A Shevorykin  2 , Y Zhao  3 , T K Killeen  4 , A G Bauer  5 , A A Morgan-López  6 , S E Back  4 , S Fitzpatrick  7 , T López-Castro  8 , S B Norman  9 , L M Saavedra  6 , D A Hien  5
Affiliations
Clinical Trial

Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics

L M Ruglass et al. Drug Alcohol Depend. .

Abstract

Background: Self-report measures are important in substance use assessment, yet they are susceptible to reporting errors. Urine drug screens (UDS) are often considered a more valid alternative. However, collecting in-person UDS may not always be feasible, contributing to the need to understand factors that influence the validity of self-reported substance use.

Methods: In this secondary analysis of data from 295 women with co-occurring PTSD and substance use disorders (SUD) who participated in a clinical trial testing behavioral interventions, we examined concordance and discordance between self-reported drug use and associated UDS results. Generalized linear mixed models were used to examine the impact of treatment type and participant characteristics on the associations between self-reported drug use and UDS results.

Results: Findings revealed higher disagreement between self-report and UDS for opioids and sedatives (ranging from.77 to.90) and lower disagreement rates for cannabis and cocaine (ranging from.26 to.33). Treatment type was not a significant moderator of the associations between self-report and UDS across all drugs. Among those with a positive opioid UDS, those who reported employment in the past three years were more likely to self-report no opioid use compared to their counterparts without employment in the past three years.

Conclusions: Findings add to the literature that supports the validity of self-reported cannabis and cocaine use. The greater discrepancies between self-report and UDS test results of opioids and sedatives suggest adjunctive UDS may be required, although a variety of factors other than inaccurate self-report may be associated with this discrepancy.

Trial registration: ClinicalTrials.gov NCT00078156.

Keywords: PTSD; Self-report; Substance use disorder; Treatment; Urine drug screen; Women.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None.

Figures

Figure 1.
Figure 1.
Predicted Probability of Reporting No Cocaine Use (Urine Positive)
See this image and copyright information in PMC

References

    1. Abraham A, & Luty J. (2010). Testing for illicit drug use in mental health services. Advances in Psychiatric Treatment, 16(5), 369–379. 10.1192/apt.bp.108.005835 - DOI
    1. Bagley SM, Cheng DM, Winter M, Alford DP, Labelle C, Walley AY, & Samet JH (2018). Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests. Drug and Alcohol Dependence, 192, 245–249. 10.1016/j.drugalcdep.2018.08.010 - DOI - PMC - PubMed
    1. Basurto FZ, Montes JMG, Cubos PF, Santed FS, Ríos FL, & Moreno AM (2009). Validity of the self-report on drug use by university students: correspondence between self-reported use and use detected in urine. Psicothema, 213–219. - PubMed
    1. Buchan BJ, Dennis ML, Tims FM, & Diamond GS (2002). Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing. Addiction, 97, 98–108. - PubMed
    1. Cacciola JS, Alterman AI, McLellan AT, Lin Y-T, & Lynch KG (2007). Initial evidence for the reliability and validity of a “Lite” version of the Addiction Severity Index. Drug and Alcohol Dependence, 87(2–3), 297–302. 10.1016/j.drugalcdep.2006.09.002 - DOI - PubMed

Publication types

MeSH terms

Associated data